Gleneagles Hospitals, Parel, Mumbai appoints Dr Bipin Chevale as CEO: Our Bureau, Mumbai Tuesday, October 8, 2024, 13:40 Hrs ...
Lombardy, the best location for pharma manufacturing in Europe: Our Bureau, Mumbai Tuesday, October 8, 2024, 16:45 Hrs [IST] Even as the global pharma industry arrives at CPHI Mil ...
BizDateUp leads US$ 1 million pre-IPO funding round in Sorich, a pharma packaging startup: Our Bureau, Bengaluru Tuesday, October 8, 2024, 17:10 Hrs [IST] BizDateUp, amongst the l ...
Dräger India gives a boost to pre-natal care with its new TN300 Open Warmer BabyRoo: Our Bureau, Bengaluru Tuesday, October 8, 2024, 13:50 Hrs [IST] Dräger India has launched Ba ...
NTC partners with Silgan Dispensing Systems to commercialize a set of new NTC proprietary eye drops with innovative Silgan technology Iridya: Milan, Italy Tuesday, October 8, 2024 ...
AstraZeneca has entered into an exclusive license agreement with CSPC Pharmaceutical Group Ltd (CSPC) to advance the development of an early stage, novel small molecule Lipoprotein (a) (Lp(a)) ...
OneSource, a multimodal global specialty pharma CDMO of Strides Group unveils new brand identity at CPHI, Milan: Our Bureau, Bengaluru Tuesday, October 8, 2024, 13:30 Hrs [IST] On ...
Immunovia acquires all blood samples required to clinically validate its next-generation test for pancreatic cancer: Lund, Sweden Tuesday, October 8, 2024, 18:00 Hrs [IST] Immunov ...
Hansa Biopharma announces positive results from NICE-01 trial of next generation IgG-cleaving molecule, HNSA-5487: Lund, Sweden Tuesday, October 8, 2024, 11:00 Hrs [IST] Hansa Bio ...
MEDICAL JAPAN 2024 to be held in Makuhari Messe, Japan from October 9 to 11: Tokyo, Japan Tuesday, October 8, 2024, 10:00 Hrs [IST] MEDICAL JAPAN 2024 returns to Makuhari Messe, J ...
Biocon Biologics’ highlights pathways to increase adoption of biosimilars in LMICs: Our Bureau, Bengaluru Tuesday, October 8, 2024, 15:30 Hrs [IST] Biocon Biologics has publishe ...
IMU Biosciences joins ground-breaking UK research consortium investigating patient response to cancer immunotherapies: London, UK Tuesday, October 8, 2024, 17:00 Hrs [IST] IMU Bio ...